STOCK TITAN

Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Amicus Therapeutics (Nasdaq: FOLD) said company management will present at two investor conferences in November 2025: the UBS Global Healthcare Conference in Palm Beach Gardens, FL on November 10, 2025 at 2:45 p.m. ET, and the Jefferies Global Healthcare Conference in London on November 18, 2025 at 4:30 p.m. GMT.

Live audio webcasts of both presentations will be available via the company’s investor relations website at https://ir.amicusrx.com/events-and-presentations. Contact details for investor and media relations were provided.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+1.46% News Effect

On the day this news was published, FOLD gained 1.46%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

PRINCETON, N.J., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in November.

  • 2025 UBS Global Healthcare Conference in Palm Beach Gardens, FL on Monday, November 10, 2025, at 2:45 p.m. ET
  • Jefferies Global Healthcare Conference 2025 in London, U.K. on Tuesday, November 18, 2025, at 4:30 p.m. GMT

A live audio webcast of each presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.

About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on LinkedIn.

CONTACT:

Investors:
Amicus Therapeutics
Andrew Faughnan
Vice President, Investor Relations
afaughnan@amicusrx.com
(609) 662-3809

Media:
Amicus Therapeutics
Brendan McEvoy
Executive Director, External Communications
bmcevoy@amicusrx.com
(609) 662-5005

FOLD–G


FAQ

When will Amicus Therapeutics (FOLD) present at the UBS Global Healthcare Conference?

Amicus will present at the UBS Global Healthcare Conference on November 10, 2025 at 2:45 p.m. ET.

What time is the Amicus (FOLD) presentation at Jefferies Global Healthcare Conference in London?

The Amicus presentation at Jefferies is scheduled for November 18, 2025 at 4:30 p.m. GMT.

How can investors access the Amicus (FOLD) conference webcasts in November 2025?

Live audio webcasts for both presentations are available via the Amicus investor relations page at https://ir.amicusrx.com/events-and-presentations.

Will Amicus (FOLD) provide a replay of the November 2025 conference presentations?

The company indicated live audio webcasts will be available; replays are typically posted on the investor relations events page after the presentation.

Who should investors contact for Amicus (FOLD) investor relations questions about the November 2025 presentations?

For investor queries contact Andrew Faughnan, Vice President, Investor Relations at afaughnan@amicusrx.com or (609) 662-3809.
Amicus Therapeut

NASDAQ:FOLD

FOLD Rankings

FOLD Latest News

FOLD Latest SEC Filings

FOLD Stock Data

4.42B
299.28M
0.71%
104.72%
7.2%
Biotechnology
Pharmaceutical Preparations
Link
United States
PRINCETON